FDA approves Pfizer’s new nasal spray treatment for migraines
(WASHINGTON) -- The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only... Read More.
Local Headlines
Current Weather
Interships
